Salix Pharmaceuticals Inc

General

Total Cases77

Active Cases7

Patents43

CourtsD. New Jersey D. Delaware N.D. West Virginia

TypeOperating Company

Elite Ratings

DCT

PTAB

salix-pharmaceuticals

salix-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L5

A

PTAB

L5

A

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
01/14/25	Bausch Health Ireland Ltd v. Mylan Pharmaceuticals Inc 1:25-CV-00003 ( N.D. WV )	VERIFICATION OF ATTORNEY ADMISSION as to Bryan Diner and Justin Hasford. (hrc) (Entered: 01/14/2025)
01/14/25	Bausch Health Ireland Ltd v. Mylan Pharmaceuticals Inc 1:25-CV-00003 ( N.D. WV )	COMPLAINT against Mylan Pharmaceuticals Inc., filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. Filing Fee $405. Receipt #AWVNDC-4072713. (Attachments: # [1] Civil Cover Sheet, # [2] Exhibit A)(hrc) (Entered: 01/14/2025)
01/06/25	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-11179 ( D. NJ )	***Civil Case Terminated. (ld, ) (Entered: 01/06/2025)
01/06/25	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-11179 ( D. NJ )	Cases associated: Create association to 2:21-cv-10057-SRC-JSA. (ld) (Entered: 01/06/2025)
01/06/25	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-07182 ( D. NJ )	***Civil Case Terminated. (ld) (Entered: 01/06/2025)
01/06/25	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-07182 ( D. NJ )	Cases associated: Create association to 2:21-cv-10057-SRC-JSA. (ld) (Entered: 01/06/2025)
12/23/24	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-11179 ( D. NJ )	ORDER CONSOLIDATING CASES; that the above-captioned cases (the "Consolidated Cases") are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; that Civil Action No. 21-10057 shall be the Lead Case and all pretrial filings going forward shall be made in Civil Action No. 21-10057 only. Signed by Magistrate Judge Jessica S. Allen on 12/19/2024. (ld, ) (Entered: 12/23/2024) ORDER CONSOLIDATING CASES; that the above-captioned cases (the "Consolidated Cases") are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; that Civil Action No. 21-10057 shall be the Lead Case and all pretrial filings going forward shall be made in Civil Action No. 21-10057 only. Signed by Magistrate Judge Jessica S. Allen on 12/19/2024. (ld, ) (Entered: 12/23/2024)
12/23/24	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-07182 ( D. NJ )	ORDER CONSOLIDATING CASES; that the above-captioned cases (the "Consolidated Cases") are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; that Civil Action No. 21-10057 shall be the Lead Case and all pretrial filings going forward shall be made in Civil Action No. 21-10057 only. Signed by Magistrate Judge Jessica S. Allen on 12/19/2024. (ld) (Entered: 12/23/2024) ORDER CONSOLIDATING CASES; that the above-captioned cases (the "Consolidated Cases") are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court; that Civil Action No. 21-10057 shall be the Lead Case and all pretrial filings going forward shall be made in Civil Action No. 21-10057 only. Signed by Magistrate Judge Jessica S. Allen on 12/19/2024. (ld) (Entered: 12/23/2024)
12/18/24	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-07182 ( D. NJ )	LETTER ORDER granting [13] Defendants' Request to adjourn the Initial Conference and the deadline to propose discovery schedule. Signed by Magistrate Judge Jessica S. Allen on 12/17/2024. (dam) (Entered: 12/18/2024)
12/17/24	Bausch Health Ireland Ltd v. MSN Laboratories Private Ltd 2:24-CV-11179 ( D. NJ )	SUMMONS ISSUED as to MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sm) (Entered: 12/17/2024)